¿Para qué se utiliza Probióticos (Lactobacillus spp., Bifidobacterium spp., Saccharomyces boulardii)?
Probióticos (Lactobacillus spp., Bifidobacterium spp., Saccharomyces boulardii) se evalúa para las siguientes indicaciones con distinto grado de evidencia: Diarrea asociada a antibióticos (nivel de evidencia B), Prevención de la recurrencia de la infección por Clostridioides difficile (nivel de evidencia C), Síndrome del intestino irritable (nivel de evidencia C). Consulta la matriz completa de indicaciones con dosis y referencias en esta misma página.
¿Cuáles son los efectos secundarios de Probióticos (Lactobacillus spp., Bifidobacterium spp., Saccharomyces boulardii)?
Efectos secundarios frecuentes de Probióticos (Lactobacillus spp., Bifidobacterium spp., Saccharomyces boulardii) (≥ 1 de cada 100): Flatulencia, molestias abdominales en los primeros días, Diarrea leve o estreñimiento (respuesta adaptativa). Consulta la sección «Seguridad» para reacciones poco frecuentes y graves.
¿Es seguro Probióticos (Lactobacillus spp., Bifidobacterium spp., Saccharomyces boulardii) durante el embarazo?
Categoría FDA B. Seguro a dosis estándar durante el embarazo. El uso para la prevención de la dermatitis atópica en recién nacidos de familias con predisposición alérgica debe consultarse con un médico.
¿Es compatible Probióticos (Lactobacillus spp., Bifidobacterium spp., Saccharomyces boulardii) con la lactancia?
Seguro durante la lactancia. No se transfiere sistémicamente desde el tracto gastrointestinal materno.
¿Quién no debe tomar Probióticos (Lactobacillus spp., Bifidobacterium spp., Saccharomyces boulardii)?
Probióticos (Lactobacillus spp., Bifidobacterium spp., Saccharomyces boulardii) está contraindicado en: Inmunodeficiencia grave (neoplasias hematológicas, VIH/sida avanzado, neutropenia grave); Catéteres venosos centrales; Pancreatitis aguda grave (según el ECA PROPATRIA: aumento de la mortalidad); Hipersensibilidad a los componentes. Lista completa en la sección «Seguridad».
I have dysbiosis, so I need a probiotic course
«gut dysbiosis» as a standalone clinical diagnosis is absent from ICD-10 and ICD-11. AGA, ACG, BSG, WGO do not recognise it. In Russian practice the diagnosis is made via stool culture – which does not reflect actual gut microbiota because 99 % of gut bacteria are strict anaerobes and do not grow on culture media. Or via the Osipov test (chromatography-mass spectrometry of microbial markers). The Russian Academy of Sciences in Memorandum No. 22 (2020) explicitly called this method pseudoscientific. «Treating dysbiosis» means treating a diagnosis that does not exist based on a test that does not work.
the Osipov test showed which bacteria are missing, so I should supplement them via probiotics
the Osipov methodology is not recognised by the international scientific community. The 2020 Memorandum No. 22 of the Russian Academy of Sciences Commission Against Pseudoscience explicitly classifies the method as pseudoscientific. Test results lack clinical interpretation. If a clinician builds treatment on Osipov test results, a second opinion is warranted.
probiotics restore microbiota after antibiotics
native microbiota recovers over 2–8 weeks regardless of probiotic intake. Probiotics reduce antibiotic-associated diarrhoea risk but do not restore microbiota composition. The 2018 Cochrane review showed no recovery effect in adults.
probiotics treat acne through the gut-skin axis
AAD Acne Guidelines 2024 and EDF 2024 do not recommend probiotics in acne. Clinical evidence is absent. Standard acne therapy: topical retinoids, benzoyl peroxide, systemic antibiotics, or isotretinoin when needed.
probiotics aid weight loss
systematic reviews showed weight reduction of 0.6 kg over 12 weeks – clinically insignificant. Endocrine Society and other obesity societies do not include probiotics in recommendations.
psychobiotics treat depression and anxiety
APA, NICE Mental Health, and WFSBP do not include probiotics in depression or anxiety recommendations. The «gut-brain axis» marketing outpaces clinical evidence.
probiotics improve the condition of children with autism
Cochrane 2018 and 2021–2023 updates did not show convincing effects on ASD symptoms. AAP and AACAP do not support the practice. Positioning probiotics as «autism treatment» is financial exploitation of families and distraction from evidence-based interventions (behavioural therapy, early intervention).
more strains in the bottle means better effect
effects are strain-specific. «Multi-strain complexes of 15 cultures» are marketing. Clinical RCTs tested specific strains: Lactobacillus rhamnosus GG, Saccharomyces boulardii, Bifidobacterium infantis 35624. Data on one strain do not transfer to others.
probiotics are absolutely safe for everyone
in immunocompromised patients and people with central venous catheters there is a risk of bacteraemia and fungaemia. In severe acute pancreatitis, the multicentre PROPATRIA RCT 2008 showed increased mortality with probiotic use.